Dyslexia Treatment Market, Global Outlook and Forecast 2022-2028

February 2022 | 62 pages | ID: DAF8802A4EB5EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Dyslexia Treatment in Global, including the following market information:

Global Dyslexia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Dyslexia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dyslexia Treatment include GlaxoSmithKline, Pfizer, Novrtis, Casper Pharma, Teva Pharmaceutical Industries Ltd., UCB S.A., Alkem Labs, Crecent Therapeutics Limited and Baxter, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dyslexia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dyslexia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Dyslexia Treatment Market Segment Percentages, by Type, 2021 (%)

• Oral
• Parenteral
• Others

Global Dyslexia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Dyslexia Treatment Market Segment Percentages, by Application, 2021 (%)

• Psychiatric Institutions
• Rehabilitation Centers
• Home Care
• Others

Global Dyslexia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Dyslexia Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dyslexia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Dyslexia Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Pfizer
• Novrtis
• Casper Pharma
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.
• Alkem Labs
• Crecent Therapeutics Limited
• Baxter
• Intas Pharmaceuticals Ltd.
• Brown & Burk

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dyslexia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dyslexia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DYSLEXIA TREATMENT OVERALL MARKET SIZE

2.1 Global Dyslexia Treatment Market Size: 2021 VS 2028
2.2 Global Dyslexia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Dyslexia Treatment Players in Global Market
3.2 Top Global Dyslexia Treatment Companies Ranked by Revenue
3.3 Global Dyslexia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Dyslexia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dyslexia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dyslexia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Dyslexia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Dyslexia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Dyslexia Treatment Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Parenteral
  4.1.4 Others
4.2 By Type - Global Dyslexia Treatment Revenue & Forecasts
  4.2.1 By Type - Global Dyslexia Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Dyslexia Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Dyslexia Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dyslexia Treatment Market Size, 2021 & 2028
  5.1.2 Psychiatric Institutions
  5.1.3 Rehabilitation Centers
  5.1.4 Home Care
  5.1.5 Others
5.2 By Application - Global Dyslexia Treatment Revenue & Forecasts
  5.2.1 By Application - Global Dyslexia Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Dyslexia Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Dyslexia Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Dyslexia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Dyslexia Treatment Revenue & Forecasts
  6.2.1 By Region - Global Dyslexia Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Dyslexia Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Dyslexia Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Dyslexia Treatment Revenue, 2017-2028
  6.3.2 US Dyslexia Treatment Market Size, 2017-2028
  6.3.3 Canada Dyslexia Treatment Market Size, 2017-2028
  6.3.4 Mexico Dyslexia Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Dyslexia Treatment Revenue, 2017-2028
  6.4.2 Germany Dyslexia Treatment Market Size, 2017-2028
  6.4.3 France Dyslexia Treatment Market Size, 2017-2028
  6.4.4 U.K. Dyslexia Treatment Market Size, 2017-2028
  6.4.5 Italy Dyslexia Treatment Market Size, 2017-2028
  6.4.6 Russia Dyslexia Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Dyslexia Treatment Market Size, 2017-2028
  6.4.8 Benelux Dyslexia Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Dyslexia Treatment Revenue, 2017-2028
  6.5.2 China Dyslexia Treatment Market Size, 2017-2028
  6.5.3 Japan Dyslexia Treatment Market Size, 2017-2028
  6.5.4 South Korea Dyslexia Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Dyslexia Treatment Market Size, 2017-2028
  6.5.6 India Dyslexia Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Dyslexia Treatment Revenue, 2017-2028
  6.6.2 Brazil Dyslexia Treatment Market Size, 2017-2028
  6.6.3 Argentina Dyslexia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Dyslexia Treatment Revenue, 2017-2028
  6.7.2 Turkey Dyslexia Treatment Market Size, 2017-2028
  6.7.3 Israel Dyslexia Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Dyslexia Treatment Market Size, 2017-2028
  6.7.5 UAE Dyslexia Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Dyslexia Treatment Major Product Offerings
  7.1.4 GlaxoSmithKline Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Dyslexia Treatment Major Product Offerings
  7.2.4 Pfizer Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Novrtis
  7.3.1 Novrtis Corporate Summary
  7.3.2 Novrtis Business Overview
  7.3.3 Novrtis Dyslexia Treatment Major Product Offerings
  7.3.4 Novrtis Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.3.5 Novrtis Key News
7.4 Casper Pharma
  7.4.1 Casper Pharma Corporate Summary
  7.4.2 Casper Pharma Business Overview
  7.4.3 Casper Pharma Dyslexia Treatment Major Product Offerings
  7.4.4 Casper Pharma Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.4.5 Casper Pharma Key News
7.5 Teva Pharmaceutical Industries Ltd.
  7.5.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
  7.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
  7.5.3 Teva Pharmaceutical Industries Ltd. Dyslexia Treatment Major Product Offerings
  7.5.4 Teva Pharmaceutical Industries Ltd. Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.5.5 Teva Pharmaceutical Industries Ltd. Key News
7.6 UCB S.A.
  7.6.1 UCB S.A. Corporate Summary
  7.6.2 UCB S.A. Business Overview
  7.6.3 UCB S.A. Dyslexia Treatment Major Product Offerings
  7.6.4 UCB S.A. Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.6.5 UCB S.A. Key News
7.7 Alkem Labs
  7.7.1 Alkem Labs Corporate Summary
  7.7.2 Alkem Labs Business Overview
  7.7.3 Alkem Labs Dyslexia Treatment Major Product Offerings
  7.7.4 Alkem Labs Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.7.5 Alkem Labs Key News
7.8 Crecent Therapeutics Limited
  7.8.1 Crecent Therapeutics Limited Corporate Summary
  7.8.2 Crecent Therapeutics Limited Business Overview
  7.8.3 Crecent Therapeutics Limited Dyslexia Treatment Major Product Offerings
  7.8.4 Crecent Therapeutics Limited Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.8.5 Crecent Therapeutics Limited Key News
7.9 Baxter
  7.9.1 Baxter Corporate Summary
  7.9.2 Baxter Business Overview
  7.9.3 Baxter Dyslexia Treatment Major Product Offerings
  7.9.4 Baxter Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.9.5 Baxter Key News
7.10 Intas Pharmaceuticals Ltd.
  7.10.1 Intas Pharmaceuticals Ltd. Corporate Summary
  7.10.2 Intas Pharmaceuticals Ltd. Business Overview
  7.10.3 Intas Pharmaceuticals Ltd. Dyslexia Treatment Major Product Offerings
  7.10.4 Intas Pharmaceuticals Ltd. Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.10.5 Intas Pharmaceuticals Ltd. Key News
7.11 Brown & Burk
  7.11.1 Brown & Burk Corporate Summary
  7.11.2 Brown & Burk Business Overview
  7.11.3 Brown & Burk Dyslexia Treatment Major Product Offerings
  7.11.4 Brown & Burk Dyslexia Treatment Revenue in Global Market (2017-2022)
  7.11.5 Brown & Burk Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Dyslexia Treatment Market Opportunities & Trends in Global Market
Table 2. Dyslexia Treatment Market Drivers in Global Market
Table 3. Dyslexia Treatment Market Restraints in Global Market
Table 4. Key Players of Dyslexia Treatment in Global Market
Table 5. Top Dyslexia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Dyslexia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Dyslexia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Dyslexia Treatment Product Type
Table 9. List of Global Tier 1 Dyslexia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dyslexia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Dyslexia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Dyslexia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Dyslexia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Dyslexia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Dyslexia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Dyslexia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Dyslexia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Dyslexia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Dyslexia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Dyslexia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Dyslexia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Dyslexia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Dyslexia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Dyslexia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Dyslexia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Dyslexia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Dyslexia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Dyslexia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Dyslexia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Dyslexia Treatment Product Offerings
Table 32. GlaxoSmithKline Dyslexia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Dyslexia Treatment Product Offerings
Table 35. Pfizer Dyslexia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Novrtis Corporate Summary
Table 37. Novrtis Dyslexia Treatment Product Offerings
Table 38. Novrtis Dyslexia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Casper Pharma Corporate Summary
Table 40. Casper Pharma Dyslexia Treatment Product Offerings
Table 41. Casper Pharma Dyslexia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 43. Teva Pharmaceutical Industries Ltd. Dyslexia Treatment Product Offerings
Table 44. Teva Pharmaceutical Industries Ltd. Dyslexia Treatment Revenue (US$, Mn), (2017-2022)
Table 45. UCB S.A. Corporate Summary
Table 46. UCB S.A. Dyslexia Treatment Product Offerings
Table 47. UCB S.A. Dyslexia Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Alkem Labs Corporate Summary
Table 49. Alkem Labs Dyslexia Treatment Product Offerings
Table 50. Alkem Labs Dyslexia Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Crecent Therapeutics Limited Corporate Summary
Table 52. Crecent Therapeutics Limited Dyslexia Treatment Product Offerings
Table 53. Crecent Therapeutics Limited Dyslexia Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Baxter Corporate Summary
Table 55. Baxter Dyslexia Treatment Product Offerings
Table 56. Baxter Dyslexia Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Intas Pharmaceuticals Ltd. Corporate Summary
Table 58. Intas Pharmaceuticals Ltd. Dyslexia Treatment Product Offerings
Table 59. Intas Pharmaceuticals Ltd. Dyslexia Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Brown & Burk Corporate Summary
Table 61. Brown & Burk Dyslexia Treatment Product Offerings
Table 62. Brown & Burk Dyslexia Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Dyslexia Treatment Segment by Type in 2021
Figure 2. Dyslexia Treatment Segment by Application in 2021
Figure 3. Global Dyslexia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dyslexia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dyslexia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dyslexia Treatment Revenue in 2021
Figure 8. By Type - Global Dyslexia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Dyslexia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Dyslexia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Dyslexia Treatment Revenue Market Share, 2017-2028
Figure 12. US Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Dyslexia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Dyslexia Treatment Revenue Market Share, 2017-2028
Figure 24. China Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Dyslexia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Dyslexia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Dyslexia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novrtis Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Casper Pharma Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Teva Pharmaceutical Industries Ltd. Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. UCB S.A. Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Alkem Labs Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Crecent Therapeutics Limited Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Baxter Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Intas Pharmaceuticals Ltd. Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Brown & Burk Dyslexia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)